Biofrontera Inc.
BFRI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001858685
No open-market purchases or sales by Biofrontera Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $2.61M in total; no superinvestor holds it.
Other share classesBFRIW
Q3 2025 vs. Q2 2025
How the institutions holding Biofrontera Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 10 | 13 | +3 |
| Shares | 2.04M | 2.42M | +381.5K (+18.7%) |
| Value | $1.45M | $2.39M | +$935.1K (+64.4%) |
New holders (5)
Institutions that held Biofrontera Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Group Inc | 113,951 | $112.2K | 0.00% |
| Two Sigma Securities, LLC | 20,787 | $20.5K | 0.00% |
| Renaissance Technologies LLC | 18,700 | $18.4K | 0.00% |
| Hunter Associates Investment Management LLC | 11,388 | $11.0K | 0.00% |
| Citigroup Inc | 5,845 | $5.76K | 0.00% |
Sold out (2)
Institutions that held Biofrontera Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Virtu Financial LLC | 21,578 | $15.0K |
| HRT Financial LP | 12,086 | $8.00K |